Sugi Predict

Sugi Predict / Compounds / SCHEMBL1626972

SCHEMBL1626972

SCHEMBL1626972

CCOC(=O)C(OC(=O)C(C)(C)c1ccc(SC)cc1)C(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ MAPT P10636 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ CNR2 P34972 6/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ NR1H4 Q96RI1 1/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ LMNA P02545 3/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KIF11 P52732 1/20 0.36
▸ RORC P51449 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1626676 0.85 CNR2 (0.46) ALDH1A1MAPTKDM4ECNR2EPHX2
SCHEMBL3836018 0.82 KIF11 (0.42) ALDH1A1MAPTEPHX2NR1H4TAS1R3
SCHEMBL1626673 0.74 PLK1 (0.47) ALDH1A1MAPTCNR2EPHX2NR1H4
SCHEMBL10443906 0.73 ALDH1A1 (0.43) ALDH1A1MAPTKDM4ETAS1R3TAS1R1
SCHEMBL11844429 0.71 ALDH1A1 (0.43) ALDH1A1MAPTKDM4ECNR2EPHX2
SCHEMBL19359885 0.70 LMNA (0.45) ALDH1A1MAPTLMNANPSR1MEN1
SCHEMBL12120740 0.70 LMNA (0.45) ALDH1A1MAPTLMNANPSR1MEN1
SCHEMBL18388298 0.70 PIN1 (0.43) ALDH1A1MAPTMEN1TSHRKMT2A
SCHEMBL8173029 0.69 CNR2 (0.48) CNR2TSHRRORC
SCHEMBL6279399 0.69 CNR2 (0.58) MAPTCNR2NPSR1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7928139-B2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof AMGEN INC. (US) 2011-04-19 — — US disclosed
US-20100048572-A1 NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF AMGEN INC. (US) 2010-02-25 — — US disclosed
US-7635715-B2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof AMGEN INC. (US) 2009-12-22 — — US disclosed
US-20090093483-A1 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof AMGEN INC. (US) 2009-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048572-A1 NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF EGLN2, EGLN3, HIF1AN ALDH1A1 128/4885MAPT 4316/4885KDM4E 977/4885
US-20090093483-A1 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof EGLN2, EGLN3, HIF1AN ALDH1A1 128/4885MAPT 4316/4885KDM4E 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.